Prognostic Stage IV Breast Cancer AJCC v8

Explore clinical trials studying Prognostic Stage IV Breast Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

37 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Prognostic Stage IV Breast Cancer AJCC v8 trial results

Active, Not Recruiting

Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

NCT05319873

Conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, +17 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases

NCT04647916

Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Brain Diseases, Brain Neoplasms, +10 more
Locations: Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

Alaska Oncology and Hematology LLC Anchorage, Alaska, United States

View all 296 locations

View Trial Details

Active, Not Recruiting

CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer

NCT05081492

Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +7 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer

NCT05215769

Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +20 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

St. Rita's Lima, Ohio, United States

Saint Francis Medical Center Richmond, Ohio, United States

Saint Elizabeth Youngstown Hospital Youngstown, Ohio, United States

View Trial Details

Active, Not Recruiting

Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer

NCT01334021

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, +20 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer

NCT04673448

Conditions: Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +53 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study

NCT04445844

Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +9 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

The Ohio State University Stefanie Spielman Comprehensive Breast Center Columbus, Ohio, United States

View Trial Details

Prognostic Stage IV Breast Cancer AJCC v8

Prognostic Stage IV Breast Cancer AJCC v8 trial results

Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases

CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer

A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer

Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer

Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer

INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study

Related conditions